Omnicell
OMCL
231 hedge funds and large institutions have $1.75B invested in Omnicell in 2018 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 81 increasing their positions, 80 reducing their positions, and 35 closing their positions.
14% more first-time investments, than exits
New positions opened: 40 | Existing positions closed: 35
2% more funds holding
Funds holding: 227 → 231 (+4)
1% more repeat investments, than reductions
Existing positions increased: 81 | Existing positions reduced: 80
4% less call options, than puts
Call options by funds: $1.09M | Put options by funds: $1.13M
3.77% less ownership
Funds ownership: 103.78% → 100% (-3.8%)
6% less capital invested
Capital invested by funds: $1.87B → $1.75B (-$121M)
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
Top Buyers
Top Sellers
OMCL Hedge Fund Activity: Q1 2018 in Review
231 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Omnicell (OMCL) for Q1 2018, worth a combined $1.75B — down 6.5% from $1.87B a quarter earlier.
Buyers outnumbered sellers: 40 funds opened new OMCL positions and 35 closed out — a net gain of 5 holders — while 81 added to existing stakes and 80 trimmed.
The largest buyer was Cramer Rosenthal McGlynn, adding an estimated $52.9M. The largest seller was Daruma Capital Management, exiting entirely with an estimated $47.1M sold.
- 231 institutional investors held Omnicell (OMCL) as of Q1 2018, up from 227 in Q4 2017.
- Funds reported $1.75B of Omnicell stock for Q1 2018, down 6.5% quarter-over-quarter.
- 40 funds opened new Omnicell positions in Q1 2018 and 35 closed out, a net change of +5 holders.
- The largest Omnicell buyer in Q1 2018 was Cramer Rosenthal McGlynn, an estimated $52.9M added.
- The largest Omnicell seller in Q1 2018 was Daruma Capital Management, an estimated $47.1M sold.
Based on aggregated 13F filings for Q1 2018.